Amorepacific Ventures

Kim Yun-kyoung leads the day-to-day investment operations as Head of Amorepacific Ventures, operating from both Seoul and San Francisco. Ultimate investment authority rests with Chairman Suh Kyung-bae, who controls the Amorepacific Group and serves as the firm's sole LP through the family’s corporate holdings.

The firm operates as a hybrid. It is entirely capitalized by the Suh family's controlling interest in Amorepacific Group, making it functionally a single-family office. However, its mandate requires that investments align strategically with the parent cosmetics company, and portfolio companies often receive access to Amorepacific's R&D labs, manufacturing, and retail distribution — a structure that mirrors a corporate venture capital arm.

The firm pursues a direct-only strategy, writing equity and co-investment checks into Seed and Series A companies. There is no public record of the vehicle participating in LP commitments to external venture capital or private equity funds.

The firm concentrates on beauty and personal-care technology, digital health, artificial intelligence, and enterprise software with consumer-facing applications. Its strategic thesis focuses on innovations that can eventually integrate into Amorepacific's broader K-beauty ecosystem, including personalized skin diagnostics, genomic skincare, and next-generation e-commerce tools.

The parent group maintains the Amorepacific Foundation, established in 1954, which operates independently from the venture arm. The foundation focuses on arts patronage and cultural preservation, including the high-profile repatriation of a rare Joseon Dynasty Moon Jar to South Korea in 2023. Amorepacific Ventures has no philanthropic mandate and is strictly a for-profit investment vehicle.

Deployment concentrates on South Korea and the United States, with the firm maintaining offices in both Seoul and San Francisco. A smaller allocation targets select opportunities in Southeast Asia, leveraging the parent group's established commercial presence in markets like Thailand and Vietnam.

The firm actively co-invests alongside established US and Korean venture capital funds through direct equity stakes and special-purpose vehicles. This collaborative approach pairs external financial validation with the strategic benefit of Amorepacific's corporate resources, making the vehicle an attractive syndicate partner for early-stage beauty-tech rounds.